The fourth annual MIP US Patent Forum returned to Silicon Valley on March 15 2016.
The U.S Patent & Trademark Office show that the number of AIA petitions filed in FY2015 is more than 75 times higher than the number of CMBs and IPRs that were initiated in 2012. Moreover, after four years of operation, now is the perfect time toanalyse trends and developments in PTAB trials. It is also a good opportunity to discuss: a rise in settlements; the impact of new rule changes; and the relationship with the Federal Circuit and District Courts.Focusing on these issue, as well as zeroing in on important decisions and cases towatch, the MIP US Patent Forum, PTAB 2016 equipped delegates with the knowledge required to improve their workloads. It shed light on strategies for litigating at the PTAB, delved into pertinent statistics and gave analysis on specific sectors, such as pharmaceuticals.The MIP US Patent Forum, PTAB brought together world leaders in corporations, industry associations, and international leading experts to discuss and impart valuableknowledge.Benefits of attending:
Who delegates met:
European Commission approves Qualcomm's acquisition of NXP, subject to conditions https://t.co/0LQaJUbYmm Qualcomm… https://t.co/sk8YHNFZny
easyGroup loses trade mark fight against EasyRoommate https://t.co/RbXV5TJ8Cn Property letting business doesn't inf… https://t.co/gPvR1fnvdP
RT @business: Google and Tencent have agreed to share patents https://t.co/QmS9nhkf3Y https://t.co/lc3lFOo9EF
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2018 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International